BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,958,812 | -31.0% | 156,101 | -31.5% | 0.00% | -40.0% |
| Q2 2023 | $24,579,007 | -39.4% | 227,731 | -30.1% | 0.01% | -44.4% |
| Q1 2023 | $40,587,771 | -0.4% | 325,823 | +20.1% | 0.01% | 0.0% |
| Q4 2022 | $40,739,965 | +16.9% | 271,202 | +5.0% | 0.01% | +12.5% |
| Q3 2022 | $34,840,000 | -7.5% | 258,301 | +2.2% | 0.01% | 0.0% |
| Q2 2022 | $37,677,000 | -63.3% | 252,698 | -58.0% | 0.01% | -63.6% |
| Q1 2022 | $102,537,000 | -40.1% | 601,177 | -9.4% | 0.02% | -35.3% |
| Q4 2021 | $171,075,000 | +63.7% | 663,593 | +73.3% | 0.03% | +54.5% |
| Q3 2021 | $104,503,000 | -8.7% | 382,814 | -25.2% | 0.02% | -15.4% |
| Q2 2021 | $114,522,000 | +789.1% | 511,536 | +333.7% | 0.03% | +766.7% |
| Q1 2021 | $12,881,000 | +321.9% | 117,960 | +215.0% | 0.00% | +200.0% |
| Q4 2020 | $3,053,000 | -69.6% | 37,449 | -74.2% | 0.00% | -66.7% |
| Q3 2020 | $10,056,000 | +1.8% | 145,264 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $9,881,000 | – | 148,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |